Evidence map›Paper›PMID 34611644›Full record

ArticleAmerican journal of preventive cardiology2021

Pooled Cohort Equations and the competing risk of cardiovascular disease versus cancer: Multi-Ethnic study of atherosclerosis.

Seamus P Whelton, Catherine Handy Marshall, Miguel Cainzos-Achirica, Omar Dzaye, Roger S Blumenthal, Khurram Nasir, Robyn L McClelland, Michael J Blaha

Abstract read
In one paragraph

Article in American journal of preventive cardiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Research Priorities and Future Directions in Cardio-Oncology.Current treatment options in oncology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Seamus P WheltonJohns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, 600 North Wolfe Street, Blalock 524A, Baltimore, MD 21287, United States.
Catherine Handy MarshallJohns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, 600 North Wolfe Street, Blalock 524A, Baltimore, MD 21287, United States.
Miguel Cainzos-AchiricaJohns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, 600 North Wolfe Street, Blalock 524A, Baltimore, MD 21287, United States.
Omar DzayeJohns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, 600 North Wolfe Street, Blalock 524A, Baltimore, MD 21287, United States.
Roger S BlumenthalJohns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, 600 North Wolfe Street, Blalock 524A, Baltimore, MD 21287, United States.
Khurram NasirJohns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, 600 North Wolfe Street, Blalock 524A, Baltimore, MD 21287, United States.
Robyn L McClellandDepartment of Biostatistics, University of Washington, United States.
Michael J BlahaJohns Hopkins Ciccarone Center for Prevention of Cardiovascular Disease, 600 North Wolfe Street, Blalock 524A, Baltimore, MD 21287, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundmany of the modifiable variables in the Pooled Cohort Equations (PCE) are shared risk factors for cardiovascular disease (CVD) and cancer, which are the two leading causes of death in the United States. We sought to determine the utility of the PCE risk for the synergistic risk prediction of CVD and cancer.

methodswe identified 5,773 participants (61.5 years and 53% women) without baseline CVD or cancer from the Multi-Ethnic study of atherosclerosis. The primary outcome was time to first event of either incident CVD or incident cancer. We calculated competing risk and cause-specific hazard models to examine the association of the PCE groups (<7.5%, 7.5-<20%, ≥20%) with the competing risk of CVD and cancer.

resultsthe rate of incident CVD and cancer was higher with higher PCE risk, but the absolute event rate was low for both CVD and cancer when the PCE risk was <7.5%. Participants with a PCE <7.5% had a higher rate of cancer (4.8) compared to CVD (3.3) per 1000 person-years, while the rate of CVD (11.5) was higher than cancer (8.6) for PCE between 7.5 and <20%. The ratio of CVD to cancer increased in a logarithmic manner and at a PCE risk of approximately 7.2% the risk for CVD and cancer was equal. In adjusted competing risk modeling, a PCE risk of ≥20% compared to <7.5% was associated with a greater risk of both CVD [7.18 (95% CI 5.77-8.94)] and cancer [3.59 (95% CI 2.91-4.43)].

conclusionsthese findings highlight the importance of age and modifiable risk factors for CVD and cancer prevention. In addition, it suggests that the PCE can provide important information for both CVD and cancer risk stratification, which may guide a synergistic approach to screening and preventive therapies for the two leading causes of death in the United States.

Indexed as

CancerCardiovascular diseaseCompeting risksRisk predictionScreening

Identifiers

PMID34611644
PMCPMC8387297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.